Rs895819 within miR-27a Might be Involved in Development of Non Small Cell Lung Cancer in the Chinese Han Population

  • Ma, Ji-Yong (Department of Respiration, Nanjing First Hospital, Nanjing Medical University) ;
  • Yan, Hai-Jun (Department of Respiration, Nanjing First Hospital, Nanjing Medical University) ;
  • Yang, Zhen-Hua (Department of Respiration, Nanjing First Hospital, Nanjing Medical University) ;
  • Gu, Wei (Department of Respiration, Nanjing First Hospital, Nanjing Medical University)
  • Published : 2015.03.18


MicroRNA-27a (miR-27a) is deemed to be an oncogene that plays an important role in development of various cancers, and single nucleotide polymorphism (SNP) of miR-27a can influence the maturation or aberrant expression of hsa-miR27a, resulting in increased risk of cancer and poor prognosis for non-small cell lung cancer (NSCLC). This study aimed to assess the effects of rs895819 within miR-27a on susceptibility and prognosis of NSCLC patients in 560 clinical confirmed cases and 568 healthy check-up individuals. Adjusted odds/hazard ratios (ORs/HRs) and 95% confidential intervals (CIs) were calculated to evaluate the association between rs895819 and the risk and prognosis of NSCLC. The results showed that allele A and genotype GG of rs895819 were significantly associated with an increased risk of NSCLC (38.9% vs 30.8%, adjusted OR=1.26, 95%CI=1.23-1.29 for allele G vs A; 18.1% vs 11.7%, adjusted OR=1.67, 95%CI=1.59-1.75 for genotype GG vs AA). Moreover, positive associations were also observed in dominant and recessive models (53.7% vs 49.9%, adjusted OR=1.17, 95%CI=1.13-1.20 for GG/AG vs AA; 18.1% vs 11.7%, adjusted=1.65, 95%CI=1.58-1.73). However, no significant association was found between rs895819 and the prognosis of NSCLC in genotype, dominant and recessive models. These results suggested that miR-27a might be involved in NSCLC carcinogenesis, but not in progression of NSCLC. The allele G, genotype GG and allele G carrier (GG/AG vs AA) of rs895819 might be genetic susceptible factors for NSCLC. Further multi-central, large sample size and well-designed prospective studies as well as functional studies are warranted to verify our findings.


miR-27a;single nucleotide polymorphism;NSCLC;Chinese Han


  1. Aparicio R, Simoes da Silva CJ, and Busturia A(2015). The microRNA miR-7 contributes to the control of Drosophila wing growth. Dev Dyn, 244, 21-30.
  2. Chen W, Zheng R, Zhang S, et al (2014). Annual report on status of cancer in China, 2010. Chin J Cancer Res, 26, 48-58.
  3. Fan X, and Wu Z(2014). Effects of four single nucleotide polymorphisms in microRNA-coding genes on lung cancer risk. Tumour Biol, 35, 10815-24.
  4. Feng DD, Zhang H, Zhang P, et al (2011). Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia. J Cell Mol Med, 15, 2164-75.
  5. Feng Y, Minca EC, Lanigan C, et al (2014). High MET receptor expression but not gene amplification in ALK 2p23 rearrangement positive non-small-cell lung cancer. J Thorac Oncol, 9, 646-53.
  6. Hong MJ, Choi YY, Jang JA, et al (2013). Association between genetic variants in pre-microRNAs and survival of earlystage NSCLC. J Thorac Oncol, 8, 703-10.
  7. Joshi P, Middleton J, Jeon YJ, et al (2014). MicroRNAs in lung cancer. World J Methodol, 4, 59-72.
  8. Lambert NJ, Gu SG, and Zahler AM(2011). The conformation of microRNA seed regions in native microRNPs is prearranged for presentation to mRNA targets. Nucleic Acids Res, 39, 4827-35.
  9. Lee CB, Stinchcombe TE, Rosenman JG, et al (2006). Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: evolving role of dose-escalated conformal (3-dimensional) radiation therapy. Clin Lung Cancer, 8, 195-202.
  10. Li J, Wang Y, Song Y, et al (2014). miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells. Mol Cancer, 13, 193.
  11. Liu T, Tang H, Lang Y, et al (2009). MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett, 273, 233-42.
  12. Ma Y, Yu S, Zhao W, et al (2010). miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett, 298, 150-8.
  13. Ni N, Zhang D, Xie Q, et al (2014). Effects of let-7b and TLX on the proliferation and differentiation of retinal progenitor cells in vitro. Sci Rep, 4, 6671.
  14. Noratto GD, Jutooru I, Safe S, et al (2013). The drug resistance suppression induced by curcuminoids in colon cancer SW- 480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis. Mol Nutr Food Res, 57, 1638-48.
  15. Pan W, Wang H, Jianwei R, et al (2014). MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells. Cell Physiol Biochem, 33, 402-12.
  16. Rodriguez S, Gaunt TR, and Day IN (2009). Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol, 169, 505-14.
  17. Rupaimoole R, Wu SY, Pradeep S, et al (2014). Hypoxiamediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun, 5, 5202.
  18. Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29.
  19. Sun Q, Gu H, Zeng Y, et al (2010). Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci, 101, 2241-7.
  20. Tian Y, Fu S, Qiu GB, et al (2014). MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma. BMC Cancer, 14, 678.
  21. Wang Q, Li DC, Li ZF, et al (2011). Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Oncogene, 30, 3875-86.
  22. Wang Z, Sun X, Wang Y, et al (2014). Association between miR-27a genetic variants and susceptibility to colorectal cancer. Diagn Pathol, 9, 146.
  23. Xiong XD, Luo XP, Cheng J, et al (2014). A genetic variant in pre-miR-27a is associated with a reduced cervical cancer risk in southern Chinese women. Gynecol Oncol, 132, 450-4.
  24. Xu J, Yin Z, Shen H, et al (2013). A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population. PLoS One, 8, 79135.
  25. Yang R, Schlehe B, Hemminki K, et al (2010). A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat, 121, 693-702.
  26. Ying HQ, Wang F, He BS, et al (2014). The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis. Onco Targets Ther, 7, 1487-96.
  27. Yoon KA, Yoon H, Park S, et al (2012). The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg, 144, 794-807.
  28. Zhang H, Li M, Han Y, et al (2010). Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci, 55, 2545-51.
  29. Zhao ZG, Jin JY, Zhang AM, et al (2014). MicroRNA profile of tumorigenic cells during carcinogenesis of lung adenocarcinoma. J Cell Biochem, [Epub ahead of print].

Cited by

  1. Evaluation of miR-27a, miR-181a, and miR-570 Genetic Variants with Gallbladder Cancer Susceptibility and Treatment Outcome in a North Indian Population vol.19, pp.5, 2015,
  2. MicroRNAs and Drinking: Association between the Pre-miR-27a rs895819 Polymorphism and Alcohol Consumption in a Mediterranean Population vol.17, pp.8, 2016,